Literature DB >> 15677633

Reduction in mortality from breast cancer.

Alison L Jones.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15677633      PMCID： PMC546052          DOI： 10.1136/bmj.330.7485.205

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.

Authors:  Gianni Bonadonna; Angela Moliterni; Milvia Zambetti; Maria Grazia Daidone; Silvana Pilotti; Luca Gianni; Pinuccia Valagussa
Journal:  BMJ       Date:  2005-01-13

2.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

Authors:  R G Blanks; S M Moss; C E McGahan; M J Quinn; P J Babb
Journal:  BMJ       Date:  2000-09-16

3.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Authors:  A Howell; J Cuzick; M Baum; A Buzdar; M Dowsett; J F Forbes; G Hoctin-Boes; J Houghton; G Y Locker; J S Tobias
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

4.  Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.

Authors:  Anne Helene Olsen; Sisse H Njor; Ilse Vejborg; Walter Schwartz; Peter Dalgaard; Maj-Britt Jensen; Ulla Brix Tange; Mogens Blichert-Toft; Fritz Rank; Henning Mouridsen; Elsebeth Lynge
Journal:  BMJ       Date:  2005-01-13

5.  A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

Authors:  Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman B Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

6.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

7.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

8.  Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.

Authors:  Nicole Hébert-Croteau; Jacques Brisson; Jean Latreille; Michèle Rivard; Nadia Abdelaziz; Ginette Martin
Journal:  J Clin Oncol       Date:  2004-08-02       Impact factor: 44.544

9.  Breast carcinoma survival in Europe and the United States.

Authors:  Milena Sant; Claudia Allemani; Franco Berrino; Michel P Coleman; Tiiu Aareleid; Gilles Chaplain; Jan Willem Coebergh; Marc Colonna; Paolo Crosignani; Arlette Danzon; Massimo Federico; Lorenzo Gafà; Pascale Grosclaude; Guy Hédelin; Josette Macè-Lesech; Carmen Martinez Garcia; Henrik Møller; Eugenio Paci; Nicole Raverdy; Brigitte Tretarre; Evelyn M I Williams
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

10.  A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Authors:  R Charles Coombes; Emma Hall; Lorna J Gibson; Robert Paridaens; Jacek Jassem; Thierry Delozier; Stephen E Jones; Isabel Alvarez; Gianfilippo Bertelli; Olaf Ortmann; Alan S Coates; Emilio Bajetta; David Dodwell; Robert E Coleman; Lesley J Fallowfield; Elizabeth Mickiewicz; Jorn Andersen; Per E Lønning; Giorgio Cocconi; Alan Stewart; Nick Stuart; Claire F Snowdon; Marina Carpentieri; Giorgio Massimini; Judith M Bliss; Cornelius van de Velde
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245
View more
  3 in total

1.  Reduction in mortality from breast cancer: reasons for improved survival are more complex than suggested.

Authors:  Graeme W Morgan
Journal:  BMJ       Date:  2005-04-30

2.  An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

Authors:  Katharina Pachmann; Robert Dengler; Kurt Lobodasch; Frank Fröhlich; Torsten Kroll; Matthias Rengsberger; Rene Schubert; Ulrich Pachmann
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

3.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.